Shortened Lifespan and Lethal Hemorrhage in a Hemophilia A Mouse Model
- PMID: 27144769
- PMCID: PMC4856382
- DOI: 10.1371/journal.pone.0154857
Shortened Lifespan and Lethal Hemorrhage in a Hemophilia A Mouse Model
Abstract
Background: Hemophilia A animal models have helped advance our understanding of factor VIII deficiency. Previously, factor VIII deficient mouse models were reported to have a normal life span without spontaneous bleeds. However, the bleeding frequency and survival in these animals has not been thoroughly evaluated.
Objective: To investigate the survival and lethal bleeding frequency in two strains of E-16 hemophilia A mice.
Methods: We prospectively studied factor VIII deficient hemizygous affected males (n = 83) and homozygous affected females (n = 55) for survival and bleeding frequency. Animals were evaluated for presence and location of bleeds as potential cause of death.
Results and conclusions: Hemophilia A mice had a median survival of 254 days, which is significantly shortened compared to wild type controls (p < 0.0001). In addition, the hemophilia A mice experienced hemorrhage in several tissues. This previously-underappreciated shortened survival in the hemophilia A murine model provides new outcomes for investigation of therapeutics and also reflects the shortened lifespan of patients if left untreated.
Conflict of interest statement
Figures


Similar articles
-
Clinical pattern of hemophilia and causes of variability.Blood Coagul Fibrinolysis. 2019 Sep;30(1S Suppl 1):S4-S6. doi: 10.1097/MBC.0000000000000821. Blood Coagul Fibrinolysis. 2019. PMID: 31517708
-
Clinical progress in gene therapy: sustained partial correction of the bleeding disorder in patients suffering from severe hemophilia B.Hum Gene Ther. 2012 Jan;23(1):4-6. doi: 10.1089/hum.2011.221. Hum Gene Ther. 2012. PMID: 22149214 No abstract available.
-
In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.Mol Ther. 2001 Jun;3(6):850-6. doi: 10.1006/mthe.2001.0325. Mol Ther. 2001. PMID: 11407898
-
Bispecific antibody mimicking factor VIII.Thromb Res. 2016 May;141 Suppl 2:S34-5. doi: 10.1016/S0049-3848(16)30361-9. Thromb Res. 2016. PMID: 27207420 Review.
-
Platelets and hemophilia: A review of the literature.Thromb Res. 2017 Jul;155:131-139. doi: 10.1016/j.thromres.2017.05.013. Epub 2017 May 13. Thromb Res. 2017. PMID: 28550758 Review.
Cited by
-
Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice.Nat Commun. 2024 Aug 21;15(1):7193. doi: 10.1038/s41467-024-51296-8. Nat Commun. 2024. PMID: 39168991 Free PMC article.
-
Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis.bioRxiv [Preprint]. 2024 Mar 3:2024.02.28.582609. doi: 10.1101/2024.02.28.582609. bioRxiv. 2024. Update in: Blood Adv. 2025 Jul 8;9(13):3136-3148. doi: 10.1182/bloodadvances.2024013143. PMID: 39896458 Free PMC article. Updated. Preprint.
-
Analyses of hemorrhagic diathesis in high-iron diet-fed rats.J Toxicol Pathol. 2021 Jan;34(1):33-41. doi: 10.1293/tox.2020-0004. Epub 2020 Oct 24. J Toxicol Pathol. 2021. PMID: 33627943 Free PMC article.
-
Preclinical Evaluation of Safety and Biodistribution of Red Cell Microparticles: A Novel Hemostatic Agent.J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):474-483. doi: 10.1177/1074248419838512. Epub 2019 Apr 29. J Cardiovasc Pharmacol Ther. 2019. PMID: 31035782 Free PMC article.
-
Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis.Blood Adv. 2025 Jul 8;9(13):3136-3148. doi: 10.1182/bloodadvances.2024013143. Blood Adv. 2025. PMID: 40085950 Free PMC article.
References
-
- Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD and Kazazian HH Jr. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nature Genetics. 1995;10:119–21. - PubMed
-
- Bi L, Sarkar R, Naas T, Lawler AM, Pain J, Shumaker SL, et al. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood. 1996;88:3446–50. - PubMed
-
- Larsson SA. Life expectancy of Swedish haemophiliacs, 1831–1980. British J of Haematology. 1985;59:593–602. - PubMed
-
- Ikkala E, Helske T, Myllyla G, Nevanlinna HR, Pitkanen P and Rasi V. Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930–79. Br J Haematol. 1982;52:7–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases